EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIV-1 transcription dominates over host gene activity at the HIV-1 integration site

Samuel Weissman iD, Yang-Hui J Yeh, Miriam Viazmenski, Rachel Kim, Jack A Collora, Savannah Steinhauser, Ya-Chi Ho iD

mBio · 2026

DOI: 10.1128/mbio.02755-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2026. Verfasst von Samuel Weissman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: HIV-1, Virus Integration, HIV Infections, Transcription, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDA NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite effective antiretroviral therapy (ART), HIV-1 persists as an integrated DNA provirus in the genome of infected cells. Host cells can regulate HIV-1 transcription at the HIV-1 integration site dependent on the location (actively transcribed genes vs repressive chromatin) and the orientation (in the same vs opposite orientation of the host gene transcription) of HIV-1 integration. Presumably, HIV-1 follows the host gene transcriptional activity at the HIV-1 integration site. We interrogated HIV-1-host gene transcriptional interactions at the HIV-1 integration site using CRISPR-mediated activation and inhibition of the host genes (in which HIV-1 was integrated) in seven HIV-1-infected Jurkat T cell clones with known HIV-1 integration sites in the introns of actively transcribed genes and a non-genic region. Using ATAC-seq and strand-specific RNA-seq to examine chromatin accessibility and RNA transcription levels, we found that host gene activation did not increase HIV-1 transcription, while host gene inhibition did not decrease HIV-1 transcription. HIV-1 drove high levels of aberrant host RNA transcription regardless of the HIV-1 integration orientation. HIV-1-driven aberrant host RNA transcription was inhibited by CRISPR-mediated HIV-1 inhibition but not by CRISPR-mediated host gene activation or inhibition. When HIV-1 was integrated into a non-genic region, HIV-1 increased host chromatin accessibility and drove high levels of aberrant host RNA transcription. Overall, HIV-1 LTR promoter-driven transcriptional activity dominated over the host promoter activity. HIV-1 transcription does not passively follow host gene activity. Our results highlight that despite effective ART, silencing HIV-1 promoter is required to inhibit HIV-1-driven aberrant host gene expression and chronic immune activation. IMPORTANCE HIV-1 persists as an integrated provirus in infected cells. Antiretroviral therapy (ART) does not inhibit HIV-1 promoter activity. Therefore, despite effective ART, HIV-1 promoter continues to drive HIV-1 antigen expression and induce chronic immune activation. HIV-1 eradication relies on either effective HIV-1 latency reversal (the shock-and-kill strategy) or permanent HIV-1 silencing (the block-and-lock strategy). Therefore, understanding the transcriptional regulation of HIV-1 expression is key to HIV cure. Presumably, HIV-1 transcription passively follows host gene activity at the HIV-1 integration site. Using a CRISPR-mediated host gene activation and inhibition, we found that host gene activation does not increase HIV-1 transcription, while host gene repression does not inhibit HIV-1 transcription. HIV-1 drives aberrant host RNA expression even when HIV-1 is integrated into a non-genic region. Overall, HIV-1 dominates over host gene activity at the HIV-1 integration site. Despite ART, additional strategies silencing HIV-1 promoter activity are required to halt HIV-1-induced chronic immune activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Virus IntegrationHIV InfectionsTranscription, GeneticViral TranscriptionHost-Pathogen InteractionsHumansJurkat CellsProvirusesChromatin

Stichwörter der Autor:innen

CRISPR activation and inhibitionHIV cureHIV-1 integration siteinsertional mutagenesistranscriptional interference

Substanzen

Chromatin

Autor:innen und Institutionen

  • Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, USA.

ORCID-Profile: Samuel Weissman, Ya-Chi Ho

Förderung

  • NIAID NIH HHS
  • NIDA NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute on Drug Abuse

Zitieren

APA

Weissman, S., Yeh, Y. H. J., Viazmenski, M., Kim, R., Collora, J. A., Steinhauser, S., & Ho, Y. C. (2026). HIV-1 transcription dominates over host gene activity at the HIV-1 integration site. mBio. https://doi.org/10.1128/mbio.02755-25

Vancouver

Weissman S, Yeh YHJ, Viazmenski M, Kim R, Collora JA, Steinhauser S, et al. HIV-1 transcription dominates over host gene activity at the HIV-1 integration site. mBio. 2026. doi:10.1128/mbio.02755-25

BibTeX
@article{Weissman2026,
  author = {Weissman, Samuel and Yeh, Yang-Hui J and Viazmenski, Miriam and Kim, Rachel and Collora, Jack A and Steinhauser, Savannah and Ho, Ya-Chi},
  title = {HIV-1 transcription dominates over host gene activity at the HIV-1 integration site},
  journal = {mBio},
  year = {2026},
  doi = {10.1128/mbio.02755-25}
}
Kostenlos starten →